08 Sep Singapore-Based Value-Based Healthcare Acquires Majority Stake in Insular Health Care
Insular Health Care (IHC), one of the Philippines’ established health maintenance organizations, has entered a new phase in its corporate journey following the acquisition of a 60% majority stake by Singapore-based Value-Based Healthcare from The Insular Life Assurance Company, Ltd. (InLife). Founded in 1991 as a fully owned HMO subsidiary of InLife, the Company has built a strong foundation over more than three decades, steadily expanding its footprint and strengthening its role in providing healthcare access to Filipinos. The entry of a Singapore-based healthcare player marks a strategic development that is expected to enhance the Company’s capacity for innovation, broaden its reach, and position it for sustained long-term growth in an evolving healthcare landscape.
The acquisition comes on the heels of a series of significant milestones that have defined the Company’s recent trajectory. In 2019, it introduced prepaid sachet-type health plans, a pioneering initiative designed to make healthcare more affordable and accessible to a wider segment of the population. This move, combined with strategic partnerships with leading e-commerce platforms, allowed the Company to extend its services beyond traditional channels and reach consumers through more convenient and digital-first touchpoints. These efforts reflect a broader commitment to inclusivity and adaptability in a rapidly changing market environment.
During the COVID-19 pandemic, IHC demonstrated resilience and a strong sense of responsibility toward its members by extending voluntary coverage, despite pandemics and epidemics being excluded under standard healthcare agreements. This proactive approach provided critical support to members during a time of uncertainty and was recognized by the International Finance Corporation (IFC), a member of the World Bank Group, for the Company’s exemplary response to the global health crisis. Such actions underscored its commitment not only to contractual obligations but also to the broader well-being of the communities it serves.
The Company’s leadership and performance have also received notable recognition. In 2020, its executive team was honored with the Circle of Excellence for Leadership Team of the Year at the Asia CEO Awards, reflecting strong governance and strategic direction. This leadership has translated into tangible results, with the Company achieving a compounded annual growth rate of 29% from 2018 to 2022. This growth surpassed its original five-year plan and propelled it from 12th to 6th place in industry rankings.
With Singapore-based Value-Based Healthcare assuming majority ownership, the Company is expected to accelerate its transformation toward more value-driven healthcare delivery. The partnership brings opportunities to integrate global expertise, enhance product innovation, and strengthen capabilities in preventive, data-driven, and outcomes-focused care. As the healthcare sector continues to evolve, IHC remains committed to its mission of delivering accessible, reliable, and sustainable healthcare solutions, now reinforced by a strategic alliance that positions it to better serve the needs of Filipinos in the years ahead.
